They could have done a deal earlier if they sold out cheaper, but in the interests of us, it is taking a little longer!
Remember they are dealing with third parties, and lots of them.
ok, one could whinge "well they should have thought about that before stating the end of March". But it still gives us some guidence. Mid April is close enough. If you can't deal with that DON'T INVEST IN BIOTECH's, unless you want something to moan about.
And Patrolly, stop quoting "in june last year". the company never said that. It was a miss-quote by somebody else. It's not TIS's fault if somebody makes a mistake.
cheers
TIS Price at posting:
69.6¢ Sentiment: Buy Disclosure: Held